Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Copano Energy LLC (NASDAQ: CPNO)


Print article Print article
© Marketwire 2013
2013-02-07 21:53:16 -

OKLAHOMA CITY, OK -- (Marketwire) -- 02/07/13 -- On February 1, 2013, a class action lawsuit was filed in the District Court for Harris County, Texas against Keryx Biopharmaceuticals, Inc. (NASDAQ: CPNO). The complaint alleges breach of fiduciary duties arising out of the Copano's attempt to sell the Company to Kinder Morgan Energy Partners, L.P. ("KMP") by means of an unfair process and for an unfair price, and whether the Copano Board of Directors breached their fiduciary duties by failing to adequately shop the Company before entering into this transaction.





On January 29, 2013, the Company announced an agreement to sell to KMP. Under the terms of the agreement, Copano shareholders will receive 0.4563 of a KMP share for each share of Copano they own, representing a value of approximately $40.91 a share. The transaction has a total approximate value of $5 billion, including the assumption of debt.



If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:




William B. Federman
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: wbf@federmanlaw.com :
Or, visit the firm's website at www.federmanlaw.com : www.federmanlaw.com/



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com